<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0809211028
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AUGMENTIN 625 MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMOXICILLIN,CLAVULANIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500,125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        63.80
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SMIITHKLINE BEECHAM" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SMIITHKLINE BEECHAM
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            GLAXO SAUDI ARABIA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01CR02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Augmentin is an antibiotic used in adults and children to treat infections in different parts of the body caused by certain types of bacteria.</p><p>Augmentin contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin is a penicillin antibiotic. Amoxicillin can sometimes be stopped from working (made inactive). The other active medicine, clavulanic acid, stops this from happening.</p><p>&nbsp;</p><p>Augmentin is used in adults and children to treat the following infections:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Upper respiratory tract infections (including ENT).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lower respiratory tract infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Genito-urinary tract infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and soft tissue infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bone and joint infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dental infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other infections e.g. infection in abdomen.</p><p>&nbsp;</p><p>Ask your doctor or pharmacist if you would like any further explanation about these uses</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Augmentin:&nbsp; </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you&rsquo;re allergic (hypersensitive) to amoxicillin, clavulanic acid, other penicillin based antibiotics, or similar antibiotics called cephalosporins.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have ever had liver problems or jaundice (yellowing of the skin and/or whites of the eyes) when taking an antibiotic.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you think any of these apply to you, check with your doctor before you take Augmentin.</p><p>&nbsp;</p><p>Take special care with Augmentin<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_3002496e-138b-41a5-b5a3-227e703932bc \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Before you take Augmentin, your doctor needs to know:</p><p>&bull; if you have ever had an <strong>allergic</strong> <strong>reaction</strong> to any other antibiotics or medicines. This might include a skin rash or swelling of the face or neck.</p><p>&bull; if you have glandular fever (mononucleosis)<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_7dc9db43-9f34-4747-9f8d-dd98573b1029 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>&bull; if you&rsquo;re taking medicines, such as warfarin, that are used to <strong>prevent blood clots</strong></p><p>&bull; If you have liver problems<!--[if supportFields]><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_aa0081b6-2e2f-45c9-87c9-23d0a80a9009 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&nbsp;&bull; if you have kidney disease<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_f85ff4d5-dfe5-4e90-b1bc-0ee0f1f71214 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>&bull; if you&rsquo;re not <strong>urinating</strong> <strong>regularly </strong>or not able to <strong>drink</strong> very much.</p><p>&egrave; <strong>Check with your doctor</strong> if you think any of these may apply to you. Your doctor will decide whether Augmentin is suitable for you and may need to adjust your dose or give you a different medicine.<strong> </strong></p><p>&nbsp;</p><p>Look out for important symptoms <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_8137500a-a96e-4c67-9dd1-d5b9478aaf21 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Augmentin can make some existing conditions worse, or cause serious side effects, such as <strong>severe allergic reactions, serious skin reactions, chest pain, </strong><strong>repetitive vomiting within 1 to 4 hours of Augmentin administration, serious liver problems or severe diarrhoea </strong>or<strong> inflammation of the large intestines (pseudomembranous colitis)</strong>. You must look out for certain symptoms while you&rsquo;re taking Augmentin to help reduce the risk of any problems. See &lsquo;<em>Look out for important symptoms</em>&rsquo; in <strong>Section 4</strong>.</p><p>&nbsp;</p><p>While you&rsquo;re taking Augmentin <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_21722861-2700-4994-93a9-1cb10d5c6b92 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Other medicines and Augmentin <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_29f53b63-6e74-4c67-87a3-bdbaed67fed6 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p><strong>Tell your doctor or pharmacist if you&#39;re taking any other medicines</strong>, if you&rsquo;ve taken any recently, or if you start taking new ones. This includes medicines bought without a prescription.</p><p>&nbsp;</p><p>Some medicines may affect how<strong><em> </em></strong>Augmentin works or make it more likely that you&rsquo;ll have side effects. Augmentin can also affect how some other medicines work. These include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; probenecid and allopurinol (used to treat gout).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>anticoagulants</strong> (used to <strong>prevent blood clots</strong>) such as warfarin and acenocoumarol.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mycophenolate mofetil (used to prevent the rejection of transplanted organs).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; methotrexate (used to treat conditions such as cancer and severe psoriasis).</p><p>&egrave; Tell your doctor or pharmacist if you&rsquo;re taking any of these.</p><p>&nbsp;</p><p>Augmentin may reduce how well the <strong>contraceptive pill</strong> works. If you&rsquo;re taking the contraceptive pill while you&rsquo;re being treated with Augmentin, you should also use a <strong>barrier method of contraception</strong> (such as condoms). Ask your doctor for advice.</p><p><strong>Pregnancy and breast-feeding&nbsp; </strong></p><p>If you&rsquo;re <strong>pregnant</strong>, or <strong>think you could be</strong>, or if you&rsquo;re <strong>planning to become pregnant</strong>, <strong>don&rsquo;t take Augmentin</strong> without checking with your doctor. <strong>Your doctor</strong> will consider the benefit to you and the risk to your baby of taking Augmentin while you&rsquo;re pregnant.</p><p>You can usually breast-feed while you&rsquo;re taking Augmentin. If you&rsquo;re breast-feeding or considering breast-feeding, <strong>check with your doctor before you take Augmentin</strong>.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Augmentin exactly as your doctor has told you to. Check with your doctor or pharmacist if you&#39;re not sure</p><p>&nbsp;</p><p><strong>How much to take&nbsp; </strong></p><p>Your doctor will decide on the correct dosage for you</p><p>Patients with kidney or liver problems<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_1a72f12e-4a16-4a9d-b6b5-83e130ffa592 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have kidney problems, your doctor may give you a different strength or a different medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have liver problems, you may have more frequent blood tests to check how your liver is working.</p><p>How to take <!--[if supportFields]><span style='mso-element:
field-begin'></span><span style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_18fe5499-bda4-4ac0-8ab2-da4f60c860e3 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take Augmentin at the start of a meal or slightly before.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets whole with a glass of water.</p><p>Do not take Augmentin for more than 14 days. If you still feel unwell you should go back to <strong>see your doctor</strong>.</p><p><strong>&nbsp;</strong></p><p>If you forget to take Augmentin <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_6c673ecd-8668-41ba-b40f-ec2712081274 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p><strong>Don&#39;t take a double dose to make up for a missed dose</strong>. Just take it as soon as you remember.</p><p>If you&rsquo;re not sure what to do, ask your doctor or pharmacist.<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_f509821e-632a-4da6-acc8-a616a90bb463 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-weight:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>&nbsp;If you take too much Augmentin <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_19ed282a-83a9-4c98-a097-57b9c2a2ad17 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>If you accidently take<em> </em>too much Augmentin it is unlikely to cause any serious problems. The most common side effects of taking too much Augmentin are nausea, vomiting and diarrhoea. If you&rsquo;re worried, or you feel unwell:</p><p>&egrave; Ask your doctor or pharmacist for advice.</p><p>Don&rsquo;t stop taking Augmentin without advice <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_6273c833-7363-42a4-9538-9392264cafad \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p><strong>It is important that you take the full course of Augmentin</strong> Don&rsquo;t stop unless your doctor advises you to &ndash; even if you&rsquo;re feeling better. If you don&rsquo;t complete the full course of treatment, the infection may come back</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Augmentin can cause side effects, but not everybody gets them.</p><p>Look out for important symptoms <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_44ed1099-7a2f-491f-987e-86d0372cc6c0 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Severe allergic reactions<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_91cd090e-ff2a-4f33-b163-125ad127ea17
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These are very rare in people taking Augmentin. Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; raised, itchy rash (<em>hives</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of blood vessels (<em>vasculitis</em>) which may be visible as red or purple raised spots on the skin, but can affect other parts of the body</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, joint pain, swollen glands in the neck, armpit or groin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, sometimes of the face or mouth (<em>angioedema</em>), which may cause difficulty in swallowing or breathing</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; collapse.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain which can be a sign of a potentially serious allergic reaction called Kounis syndrome.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; repetitive vomiting (1 to 4 hours after Augmentin administration), stomach pain, abnormal drowsiness, diarrhoea and low blood pressure which can be a sign of a serious allergic reaction called drug-induced enterocolitis syndrome.</p><p>&nbsp;</p><p>&egrave;<strong>Get medical help immediately</strong> if you get any of these symptoms. <strong>Stop taking Augmentin.</strong></p><p>Serious skin reactions<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_2061d5e5-350b-46a1-a0ca-311d25c17f2f
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These are rare in people taking Augmentin. Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiforme</em>).</p><p>These are very rare in people taking Augmentin. Signs include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes, and genitals (<em>Stevens-Johnson syndrome</em>), and a more severe form, causing blisters and peeling skin on much of the body surface (<em>toxic epidermal necrolysis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a widespread, red, skin rash with small blisters containing pus (<em>exanthemous pustulosis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a red, itchy, scaly rash with blisters and bumps under the skin (<em>bullous exfoliative dermatitis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including white blood cells (<em>eosinophilia</em>) and liver enzymes) (<em>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS))</em>.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a red rash commonly seen on both sides of buttocks, upper inner thighs, armpits, neck (<em>Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE)</em>).</p><p>&egrave;<strong>Get medical help immediately </strong>if you get any of these symptoms<strong>. Stop taking Augmentin.</strong></p><p>Serious liver problems<!--[if supportFields]><span style='mso-element:
field-begin'></span> DOCVARIABLE vault_nd_35fe71ca-7c94-4b76-b780-568788aec4a0
\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>On rare occasions, medicines like Augmentin can cause liver problems, causing yellowing of the skin and/or whites of the eyes.</p><p>&egrave;Tell your doctor as soon as possible if you get any of these symptoms.</p><p>Severe diarrhoea (Pseudomembranous colitis)<!--[if supportFields]><span
style='font-style:normal'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_a1dea888-aa1b-4620-a007-ec347e7970ef \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='font-style:normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>On rare occasions, medicines like Augmentin can cause inflammation of the colon (large intestine), causing diarrhoea, usually with blood and mucus, stomach pain and fever.</p><p>&egrave;Tell your doctor as soon as possible if you get any of these symptoms.</p><p>Very common side effects <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_d0901608-7bd5-4c4b-9f06-6fa7ce6c08fc \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>more than 1 in 10</strong> people:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; &nbsp;&nbsp;&nbsp; diarrhoea (in adults).</p><p>Common side effects <!--[if supportFields]><span
style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_40bef27e-aa27-4fc2-b0bd-6157a9e6b098 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>These may affect <strong>up to 1 in 10 </strong>people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thrush (fungal infection caused by <em>Candida</em> in the vagina, mouth or skin folds)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick (<em>nausea</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea (in children).</p><p><strong>Uncommon side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 100</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; indigestion</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, bumpy rash (<em>hives</em>)</p><p>Uncommon side effects that may show up in blood tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in some substances (enzymes) produced by the liver</p><p><strong>Rare side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 1,000</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash, which may blister, and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge &ndash; <em>erythema multiform</em>e) (See <em>&lsquo;serious skin reactions&rsquo;</em> earlier in Section 4)</p><p>Rare side effects that may show up in blood tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the number of white blood cells (<em>leucopenia</em>, including <em>neutropenia)</em></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the number of cells that help blood to clot (<em>thrombocytopenia</em>)</p><p><strong>Very rare side effects&nbsp; </strong></p><p>These may affect <strong>up to 1 in 10,000</strong> people:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe allergic reactions (<em>See also <strong>&lsquo;severe allergic reactions&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious skin reactions (<em>See also <strong>&lsquo;serious skin reactions&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the liver (<em>hepatitis</em>) (<em>See also <strong>&lsquo;serious liver problems&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the whites of the eyes or skin (<em>jaundice</em>) (<em>See also <strong>&lsquo;serious liver problems&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the large intestines (<em>See also <strong>&lsquo;severe diarrhoea&rsquo;</strong> earlier in Section 4</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the kidney (<em>nephritis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; an increase in the time blood takes to clot</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; being unusually active (<em>hyperactivity</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits (<em>seizures</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; black tongue which looks hairy<strong><em> </em></strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>inflammation of the protective membrane surrounding the brain (aseptic meningitis)</em></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash with blisters arranged in a circle with central crusting or like a string of pearls (linear IgA disease).</p><p>Very rare side effects that may show up in blood or urine tests are:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe decrease in the number of white blood cells (<em>agranulocytosis</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red blood cells destroyed too quickly (<em>haemolytic anaemia</em>)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; crystals in urine</p><p>&egrave;<strong>Tell your doctor or pharmacist</strong> if any of the side effects listed becomes <strong>severe or troublesome</strong>, or if you notice any side effects not listed in this leaflet</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the sight and reach of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not take Augmentin after the expiry date shown on the pack.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in a dry place in the original packaging to protect from moisture.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contains desiccant sachet, do not remove or eat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store the open blister pouch above 25&deg;C.&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Throw away any unused tablets 30 days after first opening.</p><p>Don&rsquo;t dispose of medicines in wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Augmentin contains<!--[if supportFields]><span style='font-weight:
normal'><span style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_092b9c08-a761-471b-b3a2-53ed307aa4a6 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span style='font-weight:
normal'><span style='mso-element:field-end'></span></span><![endif]--></p><p>The active substances are amoxicillin and clavulanic acid.<strong> </strong></p><p>Augmentin tablets come in different strengths.<strong> </strong></p><p>Each tablet contains either:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amoxicillin trihydrate equivalent to 250 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid</p><p>amoxicillin trihydrate equivalent to 500 mg amoxicillin and potassium clavulanate equivalent to 125 mg clavulanic acid</p><p>&nbsp;</p><p>The other ingredients are:</p><p>Each tablet contains magnesium stearate, sodium starch glycollate, colloidal silica, microcrystalline cellulose, titanium dioxide (E171), hydroxypropyl methylcellulose, polyethylene glycol and silicone oil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Augmentin looks like and contents of the pack 
 
AUGMENTIN 375mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘Augmentin’ on one side. Blister packs of 20 in a carton. 
 
AUGMENTIN 625mg tablets: A white to off-white oval-shaped film-coated tablet debossed with ‘AC’ and a score line on one side and plain on the other side. Blister packs of 20 in a carton. 
 
Not all presentations are available in every country. 


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Augmentin</strong> is a trademark owned by or licensed to GSK group of companies</p><p>&copy; 2024 GSK group of companies. All rights reserved.</p><p><strong>&nbsp;</strong></p><p><strong>Manufactured by:</strong></p><p>SmithKline Beecham plc.* Worthing, UK.</p><p>&nbsp;</p><p><strong>Packed by &amp; MAH:</strong></p><p>Glaxo Saudi Arabia Ltd.*, Jeddah, Kingdom of Saudi Arabia.</p><p>*member of GSK group of companies.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>For any information about this medicinal product, please contact: </strong></p><p>GSK - Head Office, Jeddah</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel:&nbsp; +966-12-6536666</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mobile: +966-56-904-9882</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: gcc.medinfo@gsk.com</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://gskpro.com/en-sa/</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O Box 55850, Jeddah 21544, Kingdom of Saudi Arabia.</p><p>&nbsp;</p><p><!--[if mso & !supportInlineShapes & supportFields]><span
style='mso-element:field-begin;mso-field-lock:yes'></span><span
style='mso-spacerun:yes'> </span>SHAPE <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span><![endif]--><!--[if gte vml 1]><v:group
 id="Group_x0020_9623" o:spid="_x0000_s1028" style='width:481.9pt;height:214.5pt;
 mso-position-horizontal-relative:char;mso-position-vertical-relative:line'
 coordsize="61201,28854" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:rect id="Rectangle_x0020_1227" o:spid="_x0000_s1029" style='position:absolute;
  left:1962;top:24647;width:468;height:1876;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>.<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1228" o:spid="_x0000_s1030" style='position:absolute;
  left:2313;top:24647;width:467;height:1876;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1229" o:spid="_x0000_s1031" style='position:absolute;
  left:1962;top:26126;width:507;height:2243;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:shape id="Shape_x0020_1279" o:spid="_x0000_s1032" style='position:absolute;
  width:61201;height:28854;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="6120130,2885440" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,480823c,215265,215316,,480949,l5639181,v265684,,480949,215265,480949,480823l6120130,2404491v,265557,-215265,480949,-480949,480949l480949,2885440c215316,2885440,,2670048,,2404491l,480823xe"
  filled="f" strokeweight="2.5pt">
  <v:path arrowok="t" textboxrect="0,0,6120130,2885440"/>
 </v:shape><v:rect id="Rectangle_x0020_1280" o:spid="_x0000_s1033" style='position:absolute;
  left:2480;top:2076;width:31133;height:2645;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>To
     report any side effect(s):</span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1281" o:spid="_x0000_s1034" style='position:absolute;
  left:25892;top:2076;width:659;height:2645;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1282" o:spid="_x0000_s1035" style='position:absolute;
  left:2480;top:4119;width:659;height:2644;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1283" o:spid="_x0000_s1036" style='position:absolute;
  left:2480;top:6159;width:22206;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Kingdom of Saudi Arabia</span></i></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1284" o:spid="_x0000_s1037" style='position:absolute;
  left:19171;top:6159;width:519;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span></span></i></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1285" o:spid="_x0000_s1038" style='position:absolute;
  left:2480;top:7759;width:621;height:2079;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>-</span></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1286" o:spid="_x0000_s1039" style='position:absolute;
  left:2953;top:7759;width:36542;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>National
     Pharmacovigilance centre (NPC)</span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1287" o:spid="_x0000_s1040" style='position:absolute;
  left:30434;top:7759;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1288" o:spid="_x0000_s1041" style='position:absolute;
  left:4766;top:9763;width:858;height:1702;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1289" o:spid="_x0000_s1042" style='position:absolute;
  left:5406;top:9466;width:518;height:2079;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1290" o:spid="_x0000_s1043" style='position:absolute;
  left:7052;top:9466;width:14374;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Reporting Hotline<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1291" o:spid="_x0000_s1044" style='position:absolute;
  left:17861;top:9466;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>:<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1292" o:spid="_x0000_s1045" style='position:absolute;
  left:18242;top:9466;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1293" o:spid="_x0000_s1046" style='position:absolute;
  left:18638;top:9466;width:5172;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>19999<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1294" o:spid="_x0000_s1047" style='position:absolute;
  left:22509;top:9466;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQCTXlfsxAAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9Na8JA
EL0X/A/LCL3VTYMUE11FtJIc2yjY3obsmIRmZ0N2a9L++m5B8DaP9zmrzWhacaXeNZYVPM8iEMSl
1Q1XCk7Hw9MChPPIGlvLpOCHHGzWk4cVptoO/E7XwlcihLBLUUHtfZdK6cqaDLqZ7YgDd7G9QR9g
X0nd4xDCTSvjKHqRBhsODTV2tKup/Cq+jYJs0W0/cvs7VO3rZ3Z+Oyf7Y+KVepyO2yUIT6O/i2/u
XIf5cTKH/2/CCXL9BwAA//8DAFBLAQItABQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAAAAAAAAA
AAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsA
AAAAAAAAAAAAAAAAHwEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAJNeV+zEAAAA3QAAAA8A
AAAAAAAAAAAAAAAABwIAAGRycy9kb3ducmV2LnhtbFBLBQYAAAAAAwADALcAAAD4AgAAAAA=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1295" o:spid="_x0000_s1048" style='position:absolute;
  left:4766;top:11698;width:858;height:1703;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1296" o:spid="_x0000_s1049" style='position:absolute;
  left:5406;top:11401;width:518;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1297" o:spid="_x0000_s1050" style='position:absolute;
  left:7052;top:11401;width:1244;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>E<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1298" o:spid="_x0000_s1051" style='position:absolute;
  left:7981;top:11401;width:621;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1299" o:spid="_x0000_s1052" style='position:absolute;
  left:8454;top:11401;width:4447;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>mail: <o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9458" o:spid="_x0000_s1053" style='position:absolute;
  left:11807;top:11401;width:18599;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><a
     href="mailto:npc.drug@sfda.gov.sa"><span style='font-family:"Times New Roman",serif;
     mso-fareast-font-family:"Times New Roman";color:blue;mso-fareast-language:
     EN-US'>npc.drug@sfda.gov.sa</span><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi;
     mso-ansi-language:FR'> </span></a><u><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></u></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1301" o:spid="_x0000_s1054" style='position:absolute;
  left:25801;top:11401;width:518;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1302" o:spid="_x0000_s1055" style='position:absolute;
  left:26182;top:11401;width:518;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1304" o:spid="_x0000_s1056" style='position:absolute;
  left:4766;top:13649;width:858;height:1703;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1305" o:spid="_x0000_s1057" style='position:absolute;
  left:5406;top:13352;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1306" o:spid="_x0000_s1058" style='position:absolute;
  left:7052;top:13352;width:7250;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Website:<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1307" o:spid="_x0000_s1059" style='position:absolute;
  left:12492;top:13352;width:519;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQD9Z1OBxQAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9La8JA
EL4X+h+WKXirmyq0MXUV8UFyrEawvQ3ZaRKanQ3Z1aT+erdQ8DYf33Pmy8E04kKdqy0reBlHIIgL
q2suFRzz3XMMwnlkjY1lUvBLDpaLx4c5Jtr2vKfLwZcihLBLUEHlfZtI6YqKDLqxbYkD9207gz7A
rpS6wz6Em0ZOouhVGqw5NFTY0rqi4udwNgrSuF19Zvbal832Kz19nGabfOaVGj0Nq3cQngZ/F/+7
Mx3mT6M3+PsmnCAXNwAAAP//AwBQSwECLQAUAAYACAAAACEA2+H2y+4AAACFAQAAEwAAAAAAAAAA
AAAAAAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQBa9CxbvwAAABUBAAAL
AAAAAAAAAAAAAAAAAB8BAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQD9Z1OBxQAAAN0AAAAP
AAAAAAAAAAAAAAAAAAcCAABkcnMvZG93bnJldi54bWxQSwUGAAAAAAMAAwC3AAAA+QIAAAAA
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9462" o:spid="_x0000_s1060" style='position:absolute;
  left:12889;top:13352;width:18705;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><a
     href="https://ade.sfda.gov.sa/"><span style='font-family:"Times New Roman",serif;
     mso-fareast-font-family:"Times New Roman";color:blue;mso-fareast-language:
     EN-US'>https://ade.sfda.gov.sa</span></a><u><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-fareast-font-family:
     "Times New Roman";color:blue;mso-fareast-language:EN-US'><o:p></o:p></span></u></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1309" o:spid="_x0000_s1061" style='position:absolute;
  left:26944;top:13352;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1311" o:spid="_x0000_s1062" style='position:absolute;
  left:2480;top:15196;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>-</span></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1312" o:spid="_x0000_s1063" style='position:absolute;
  left:2953;top:15196;width:4041;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQBoyWbEwwAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9Ni8Iw
EL0L/ocwwt40VUG0GkV0RY+7VlBvQzO2xWZSmqzt+us3C4K3ebzPWaxaU4oH1a6wrGA4iEAQp1YX
nCk4Jbv+FITzyBpLy6Tglxyslt3OAmNtG/6mx9FnIoSwi1FB7n0VS+nSnAy6ga2IA3eztUEfYJ1J
XWMTwk0pR1E0kQYLDg05VrTJKb0ff4yC/bRaXw722WTl53V//jrPtsnMK/XRa9dzEJ5a/xa/3Acd
5o+HI/j/Jpwgl38AAAD//wMAUEsBAi0AFAAGAAgAAAAhANvh9svuAAAAhQEAABMAAAAAAAAAAAAA
AAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEAWvQsW78AAAAVAQAACwAA
AAAAAAAAAAAAAAAfAQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAaMlmxMMAAADdAAAADwAA
AAAAAAAAAAAAAAAHAgAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAADAAMAtwAAAPcCAAAAAA==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>GSK</span></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1313" o:spid="_x0000_s1064" style='position:absolute;
  left:5985;top:15196;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1314" o:spid="_x0000_s1065" style='position:absolute;
  left:6366;top:15196;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>-</span></b><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1315" o:spid="_x0000_s1066" style='position:absolute;
  left:6838;top:15196;width:519;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1316" o:spid="_x0000_s1067" style='position:absolute;
  left:7235;top:15196;width:17840;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>Head
     Office, Jeddah</span></b><span style='font-size:11.0pt;line-height:107%;
     font-family:"Times New Roman",serif;mso-ascii-theme-font:major-bidi;
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1317" o:spid="_x0000_s1068" style='position:absolute;
  left:20650;top:15196;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><b
     style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span></b><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1318" o:spid="_x0000_s1069" style='position:absolute;
  left:4766;top:17200;width:858;height:1702;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQAJIVEuxgAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Ba8JA
EIXvBf/DMkJvdWMF0egqYit6bFVQb0N2TILZ2ZDdmtRf3zkUvM3w3rz3zXzZuUrdqQmlZwPDQQKK
OPO25NzA8bB5m4AKEdli5ZkM/FKA5aL3MsfU+pa/6b6PuZIQDikaKGKsU61DVpDDMPA1sWhX3ziM
sja5tg22Eu4q/Z4kY+2wZGkosKZ1Qdlt/+MMbCf16rzzjzavPi/b09dp+nGYRmNe+91qBipSF5/m
/+udFfzRUHDlGxlBL/4AAAD//wMAUEsBAi0AFAAGAAgAAAAhANvh9svuAAAAhQEAABMAAAAAAAAA
AAAAAAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEAWvQsW78AAAAVAQAA
CwAAAAAAAAAAAAAAAAAfAQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEACSFRLsYAAADdAAAA
DwAAAAAAAAAAAAAAAAAHAgAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAADAAMAtwAAAPoCAAAAAA==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1319" o:spid="_x0000_s1070" style='position:absolute;
  left:5406;top:16903;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1320" o:spid="_x0000_s1071" style='position:absolute;
  left:7052;top:16903;width:3091;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Tel:<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1321" o:spid="_x0000_s1072" style='position:absolute;
  left:9384;top:16903;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1322" o:spid="_x0000_s1073" style='position:absolute;
  left:9780;top:16903;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1323" o:spid="_x0000_s1074" style='position:absolute;
  left:10161;top:16903;width:4200;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>+966<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1324" o:spid="_x0000_s1075" style='position:absolute;
  left:13315;top:16903;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1325" o:spid="_x0000_s1076" style='position:absolute;
  left:13788;top:16903;width:2071;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>12<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1326" o:spid="_x0000_s1077" style='position:absolute;
  left:15327;top:16903;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1327" o:spid="_x0000_s1078" style='position:absolute;
  left:15800;top:16903;width:7239;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>6536666<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1328" o:spid="_x0000_s1079" style='position:absolute;
  left:21229;top:16903;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1329" o:spid="_x0000_s1080" style='position:absolute;
  left:4766;top:18907;width:858;height:1702;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1330" o:spid="_x0000_s1081" style='position:absolute;
  left:5406;top:18610;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1331" o:spid="_x0000_s1082" style='position:absolute;
  left:7052;top:18610;width:10704;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Mobile: +966<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1332" o:spid="_x0000_s1083" style='position:absolute;
  left:15099;top:18610;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1333" o:spid="_x0000_s1084" style='position:absolute;
  left:15571;top:18610;width:2071;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>56<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1334" o:spid="_x0000_s1085" style='position:absolute;
  left:17129;top:18610;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1335" o:spid="_x0000_s1086" style='position:absolute;
  left:17586;top:18610;width:3105;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>904<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1336" o:spid="_x0000_s1087" style='position:absolute;
  left:19918;top:18610;width:621;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>-<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1337" o:spid="_x0000_s1088" style='position:absolute;
  left:20391;top:18610;width:4121;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>9882<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1338" o:spid="_x0000_s1089" style='position:absolute;
  left:23484;top:18610;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1339" o:spid="_x0000_s1090" style='position:absolute;
  left:4766;top:20598;width:858;height:1703;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1340" o:spid="_x0000_s1091" style='position:absolute;
  left:5406;top:20302;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1341" o:spid="_x0000_s1092" style='position:absolute;
  left:7052;top:20302;width:5683;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>Email: <o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9464" o:spid="_x0000_s1093" style='position:absolute;
  left:11334;top:20302;width:933;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p>&nbsp;</o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9465" o:spid="_x0000_s1094" style='position:absolute;
  left:11355;top:20111;width:18061;height:1998;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><a
     href="mailto:saudi.safety@gsk.com"><span style='font-family:"Times New Roman",serif;
     mso-fareast-font-family:"Times New Roman";color:blue;mso-fareast-language:
     EN-US'>saudi.safety@gsk.com</span></a><u><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></u></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1344" o:spid="_x0000_s1095" style='position:absolute;
  left:25405;top:20302;width:1045;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1345" o:spid="_x0000_s1096" style='position:absolute;
  left:26182;top:20302;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1348" o:spid="_x0000_s1097" style='position:absolute;
  left:4766;top:22305;width:858;height:1703;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1349" o:spid="_x0000_s1098" style='position:absolute;
  left:5406;top:22008;width:518;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQB13tuoxAAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9La8JA
EL4L/odlBG+6qYqY6CriAz1WLdjehuyYhGZnQ3Y1sb++WxB6m4/vOYtVa0rxoNoVlhW8DSMQxKnV
BWcKPi77wQyE88gaS8uk4EkOVstuZ4GJtg2f6HH2mQgh7BJUkHtfJVK6NCeDbmgr4sDdbG3QB1hn
UtfYhHBTylEUTaXBgkNDjhVtckq/z3ej4DCr1p9H+9Nk5e7rcH2/xttL7JXq99r1HISn1v+LX+6j
DvPHkxj+vgknyOUvAAAA//8DAFBLAQItABQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAAAAAAAAA
AAAAAAAAAABbQ29udGVudF9UeXBlc10ueG1sUEsBAi0AFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsA
AAAAAAAAAAAAAAAAHwEAAF9yZWxzLy5yZWxzUEsBAi0AFAAGAAgAAAAhAHXe26jEAAAA3QAAAA8A
AAAAAAAAAAAAAAAABwIAAGRycy9kb3ducmV2LnhtbFBLBQYAAAAAAwADALcAAAD4AgAAAAA=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1350" o:spid="_x0000_s1099" style='position:absolute;
  left:7052;top:22008;width:1760;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>W<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1351" o:spid="_x0000_s1100" style='position:absolute;
  left:8378;top:22008;width:5989;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>ebsite: <o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9477" o:spid="_x0000_s1101" style='position:absolute;
  left:12889;top:22008;width:17775;height:2080;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><a
     href="https://gskpro.com/en-sa/"><span style='font-family:"Times New Roman",serif;
     mso-fareast-font-family:"Times New Roman";color:blue;mso-fareast-language:
     EN-US'>https://gskpro.com/en-sa/</span><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>
     </span></a><u><span style='font-size:11.0pt;line-height:107%;font-family:
     "Times New Roman",serif;mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:
     major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></u></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_9482" o:spid="_x0000_s1102" style='position:absolute;
  left:30843;top:20383;width:4399;height:2371;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p>&nbsp;</o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1358" o:spid="_x0000_s1103" style='position:absolute;
  left:4766;top:23997;width:858;height:1703;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Segoe UI Symbol";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'>•</span><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1359" o:spid="_x0000_s1104" style='position:absolute;
  left:5406;top:23700;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1360" o:spid="_x0000_s1105" style='position:absolute;
  left:7052;top:23700;width:37606;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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=
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'>P.O Box 55850, Jeddah 21544, Kingdom of Saudi
     Arabia.<o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1361" o:spid="_x0000_s1106" style='position:absolute;
  left:35328;top:23700;width:518;height:2079;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQDAHYvOwgAAAN0AAAAPAAAAZHJzL2Rvd25yZXYueG1sRE9Ni8Iw
EL0L/ocwgjdNXUG0GkV0RY+uCuptaMa22ExKE23115uFhb3N433ObNGYQjypcrllBYN+BII4sTrn
VMHpuOmNQTiPrLGwTApe5GAxb7dmGGtb8w89Dz4VIYRdjAoy78tYSpdkZND1bUkcuJutDPoAq1Tq
CusQbgr5FUUjaTDn0JBhSauMkvvhYRRsx+XysrPvOi2+r9vz/jxZHydeqW6nWU5BeGr8v/jPvdNh
/nA0gN9vwgly/gEAAP//AwBQSwECLQAUAAYACAAAACEA2+H2y+4AAACFAQAAEwAAAAAAAAAAAAAA
AAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQBa9CxbvwAAABUBAAALAAAA
AAAAAAAAAAAAAB8BAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQDAHYvOwgAAAN0AAAAPAAAA
AAAAAAAAAAAAAAcCAABkcnMvZG93bnJldi54bWxQSwUGAAAAAAMAAwC3AAAA9gIAAAAA
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-hansi-theme-font:major-bidi;
     mso-bidi-theme-font:major-bidi'><span style='mso-spacerun:yes'> </span><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><v:rect id="Rectangle_x0020_1362" o:spid="_x0000_s1107" style='position:absolute;
  left:2480;top:25564;width:421;height:1862;visibility:visible;
  mso-wrap-style:square;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" filled="f" stroked="f">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:
     8.0pt;margin-left:0in;text-indent:0in;line-height:107%'><span
     style='font-size:11.0pt;line-height:107%;font-family:"Times New Roman",serif;
     mso-ascii-theme-font:major-bidi;mso-fareast-font-family:"Times New Roman";
     mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><span
     style='mso-spacerun:yes'> </span></span><span style='font-size:11.0pt;
     line-height:107%;font-family:"Times New Roman",serif;mso-ascii-theme-font:
     major-bidi;mso-hansi-theme-font:major-bidi;mso-bidi-theme-font:major-bidi'><o:p></o:p></span></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
 </v:rect><w:wrap type="none"/>
 <w:anchorlock/>
</v:group><![endif]--><img width="646" height="290" src="file:///C:/Users/aa630244/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
 id="_x0000_i1025" type="#_x0000_t75" style='width:481.9pt;height:214.5pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span><![endif]--></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;<strong>THIS IS A MEDICAMENT </strong></p><p>&nbsp;&nbsp;</p><p>- Medicament is a product which affects your health, and its consumption contrary to&nbsp;&nbsp;&nbsp;&nbsp; instructions is dangerous for you.</p><p>- Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pharmacist who sold the medicament.</p><p>- The doctor and the pharmacist are experts in medicine, its benefits and risks.</p><p>- Do not by yourself interrupt the period of treatment prescribed for you.</p><p>- Do not repeat the same prescription without consulting your doctor.</p><p>- Keep all medicine out of reach of children.</p><p>Council of Arab Health Ministers</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Version number: GDS29 
Date of issue: 07 September 2023

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">أوجمنتين هو مضاد حيوي يتناوله البالغون والأطفال لعلاج الالتهابات في الأجزاء المختلفة من الجسم التي تسببها أنواع معينة من البكتيريا.&nbsp;</p><p dir="RTL">يحتوي أوجمنتين على مادتين مختلفتين، هما: الأموكسيسيلين وحمض الكلافولانيك. الأموكسيسيلين هو مضاد حيوي يحتوي على بنسلين. يمكن&nbsp; أحيانًا مقاومة الأموكسيسيلين )جعله غير فعال(، لذا تساعد المادة الفعالة الأخرى -حمض الكلافولانيك- على منع بعض البكتريا من&nbsp; أن تصبح مقاومة للأموكسيسيلين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم أوجمنتين لعلاج البالغين والأطفال لعلاج حالات&nbsp; العدوى التالية.</p><p dir="RTL">&nbsp;&bull;عدوى الجهاز التنفسي العلوي )بما في ذلك الأنف والأذن والحنجرة(.</p><p dir="RTL">&nbsp;&bull;عدوى الجهاز التنفسي السفلي.</p><p dir="RTL">&nbsp;&bull;عدوى المسالك البولية والتناسلية.</p><p dir="RTL">&nbsp;&bull;عدوى الجلد والأنسجة الرخوة.&nbsp;</p><p dir="RTL">&nbsp;&bull;عدوى العظام والمفاصل.&nbsp;</p><p dir="RTL">&nbsp;&bull;عدوى الأسنان.</p><p dir="RTL">&nbsp;&bull;أنواع أخرى من العدوى مثل العدوى البكتيرية داخل البطن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اسأل طبيبك أو الصيدلي إذا أردت أي استفسارات أخرى عن هذ ه الاستعمالات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تتناول أوجمنتين إذا:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من حساسية )حساسية شديدة( تجاه الأموكسيسيلين، أو حمض الكلافولانيك، أو المضادات الحيوية الأخرى القائمة على البنسلين، أو المضادات الحيوية المماثلة التي تسمى السيفالوسبورينات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل بالكبد أو اليرقان )اصفرار الجلد و/ أو بياض العين( عند تناول المضاد الحيوي.</p><p dir="RTL">&ccedil; إذا انطبق عليك أي مما سبق، تحدث إلى طبيبك قبل تناول أوجمنتين.</p><p dir="RTL">الاحتياطات الخاصة التي يجب مراعاتها عند تناول أوجمنتين&nbsp;</p><p dir="RTL">تحدث إلى طبيبك قبل تناول أوجمنتين إذا:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرضت من قبل لرد فعل تحسسي تجاه أي مضادات حيوية أو أدوية أخرى، وقد يشمل ذلك الطفح الجلدي أو تورم الوجه أو الرقبة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك حمى غُدِّيّة )كثرة الوحيدات العدوائية(.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تتناول الأدوية -مثل وارفارين- التي تستخدم لمنع تجلط الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل بالكبد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مرض بالكلى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت لا تتبول بانتظام أو لا تستطيع الشرب بكثرة.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&ccedil; <strong>تحدث إلى طبيبك</strong> إذا انطبق عليك أي مما سبق. سيقرر طبيبك ما إذا كان أوجمنتين مناسبًا لك وقد يحتاج إلى تعديل جرعتك أو إعطائك دواءً&nbsp; مختلفًا.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>انتبه إلى الأعراض المهمة&nbsp; </strong></p><p dir="RTL">يمكن أن يجعل أوجمنتين بعض الحالات الحالية أسوأ أو يسبب آثارًا جانبية خطيرة، مثل: <strong>ردود الفعل&nbsp; التحسسية الشديدة، أو التفاعلات الجلدية الخطيرة، ألم في الصدر، </strong><strong>القيء المتكرر خلال ساعة إلى 4 ساعات من تلقي دواء أوجمنتين</strong><strong> أو أمراض الكبد الخطيرة، أو الإسهال الشديد، أو التهاب الأمعاء الغليظة</strong><strong>)</strong><strong>التهاب القولون الغشائي الكاذب</strong><strong>(</strong>. يجب&nbsp; أن تنتبه إلى بعض الأعراض أثناء تناولك أوجمنتين للمساعدة في تقليل مخاطر حدوث أي مشكلات . انظر&quot;انتبه إلى الأعرا ض المهمة&quot; في <strong>القسم 4</strong>.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أثناء تناول أوجمنتين&nbsp; </strong></p><p dir="RTL"><strong>تفاعلات أوجمنتين مع الأدوية الأخرى&nbsp; </strong></p><p dir="RTL"><strong>يرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول</strong> أو قد تناولت مؤخرًا <strong>أية أدوية أخرى</strong> أو إذا بدأت في تناول أدوية جديدة، ويشمل ذلك تلك التي حصلت عليها دون وصفة طبية.&nbsp;</p><p>&nbsp;</p><p dir="RTL">قد تؤثر بعض الأدوية على طريقة عمل أوجمنتين أو تزيد من احتمالية الإصابة بآثار جانبية. يمكن أن يؤثر أوجمنتين أيضًا على كيفية عمل بعض الأدوية الأخرى. ويشمل ذلك ما يلي :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>البروبينسيد</strong> و<strong>الألوبيورينول</strong> )يستخدمان <strong>لعلاج النقرس</strong>(.&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مضادات التخثر</strong> ) تستخدم <strong>لمنع تجلط الدم</strong>( مثل وارفارين وأسينوكومارول.&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ميكوفينولات موفيتيل</strong> ) يستخدم <strong>لمنع رفض الأعضاء المزروعة</strong><strong>(</strong>.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميثوتريكسات (يستخدم لعلاج حالات مثل السرطان والصدفية الشديدة).</p><p dir="RTL">&ccedil; يرجى إبلاغ طبيبك أو الصيدلي إذا كنت تتناول أي مما سبق.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يقلل أوجمنتين من مدى فاعلية <strong>حبوب منع الحمل</strong>. إذا كنتِّ&nbsp; تستخدمين حبوب منع الحمل أثناء تناولك أوجمنتين ، فيجب عليك أيضًا استخدام <strong>وسيلة عازلة لمنع الحمل</strong> ) مثل الواقي الذكري(. اسألي طبيبك للحصول على المشورة.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية&nbsp; </strong></p><p dir="RTL">إذا كنتِّ&nbsp; <strong>حاملاً، تظنين&nbsp; أنك حاملا ً</strong> أو <strong>تخططين لإنجاب طفل</strong>، <strong>فلا&nbsp; تأخذي أوجمنتين </strong>&nbsp;دون مراجعة طبيبك. سينظر <strong>طبيبك</strong> في الفائدة التي تعود عليكِّ والمخاطرالتي يتعرض لها&nbsp; طفلك جراء تناول أوجمنتين أثناء الحمل.</p><p>يمكنك عادة الإرضاع طبيعيًا&nbsp; أثناء تناولك أوجمنتين. إذا كنتِّ&nbsp; ترضعين طفلك طبيعيًا أو&nbsp; تفكرين في الرضاعة الطبيعية، <strong>فاستشيري طبيبك قبل تناول أوجمنتين. </strong>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>احرص دائمًا على تناول أوجمنتين تمامًا كما أخبرك طبيبك أو الصيدلي.</strong> إذا لم تكن متأكدًاً من كيفية التناول، يرجى مراجعة طبيبك أو الصيدلي.&nbsp;</p><p dir="RTL"><strong>ما هي الكمية التي يجب تناولها&nbsp; </strong></p><p dir="RTL">يقرر طبيبك الجرعة المناسبة لك <strong>مرضى الكلى أو الكبد&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بالكلى، فقد يعطيك طبيبك تركيز مختلف أو دواء مختلف.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بالكبد، يلزم إجراء المزيد من تحاليل الدم لمعرفة حالة الكبد.</p><p dir="RTL"><strong>كيفية التناول&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول أوجمنتين في بداية الوجبة أو قبلها بقليل .</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابتلع القرص بالكامل مع كوب من الماء.</p><p dir="RTL">لا تتناول أوجمنتين لأكثر من 14 يومًا. إذا كنت لا تزال تشعر بأنك لست على ما يرام، يجب عليك <strong>رؤية طبيبك</strong> مرة أخرى.&nbsp;</p><p dir="RTL"><strong>في حال نسيان تناول أوجمنتين&nbsp; </strong></p><p dir="RTL"><strong>لا تتناول جرعة مضاعفة لتعويض الجرعة التي أغفلتها،</strong> فقط تناولها بمجرد تذكرك.&nbsp;</p><p dir="RTL"><strong>إذا لم تكن متأكدًا مما يجب عليك فعله</strong>، فاسأل طبيبك أو الصيدلي.</p><p dir="RTL"><strong>في حال تناول كمية أكثر مما يجب من أوجمنتين&nbsp; </strong></p><p dir="RTL">إذا تناولت كمية أكثر مما يجب من أوجمنتين عن طريق الخطأ ، فمن غير المرجح حدوث أي مشاكل خطيرة.</p><p dir="RTL">الآثار الجانبية الأكثر شيوعًا لتناول كمية أكثر مما يجب من أوجمنتين هي الغثيان والقيء والإسهال. إذا كنت قلقًا أو تشعر بتوعك:</p><p dir="RTL">&ccedil; اسأل طبيبك أو الصيدلي للحصول على المشورة.</p><p dir="RTL"><strong>لا تتوقف عن تناول أوجمنتين دون استشارة الطبيب&nbsp; </strong></p><p dir="RTL"><strong>من المهم أن تأخذ دورة كاملة من أوجمنتين</strong>. لا تتوقف عن تناول الدواء إلا إذا نصحك طبيبك بذلك، حتى لو كنت تشعر بتحسن. إذا لم تكمل دورة العلاج بالكامل، فقد تعود العدوى مرة أخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد يسبب هذا الدواء آثارًا جانبية -مثل جميع الأدوية- ومع ذلك لا يشعر بها جميع الأشخاص.&nbsp;</p><p dir="RTL"><strong>انتبه إلى الأعراض المهمة&nbsp; </strong></p><p dir="RTL"><strong>ردود الفعل التحسسية الشديدة&nbsp; </strong></p><p dir="RTL">هذه نادرة جدًاً لدى الأشخاص الذين يتناولون أوجمنتين ، وتشمل:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي المثير للحكة (الشرى(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية (الالتهاب الوعائي) الذي يمكن رؤيته على شكل بقع حمراء أو أرجوانية بارزة على الجلد، ولكن قد يؤثر على أجزاء أخرى من الجسم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى وآلام المفاصل وتورم الغدد في الرقبة أو الإبط أو الفخذ</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ الوجه أو الفم) الوذمة الوعائية(، مما قد يسبب صعوبة في البلع أو التنفس&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهبوط&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الصدر يمكن أن يكون علامة على رد فعل تحسسي خطير محتمل يسمى متلازمة كونس &nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء المتكرر (خلال ساعة إلى 4 ساعات من تلقي الدواء أوجمنتين)، آلام في المعدة، نعاس غير طبيعي، إسهال، وانخفاض ضغط الدم، والتي يمكن أن تكون علامة على رد فعل تحسسي خطير يسمى متلازمة التهاب الأمعاء والقولون الناجم عن الأدوية.</p><p dir="RTL">&ccedil; <strong>احصل على المساعدة الطبية فورًا</strong> إذا ظهرت عليك أي من هذه الأعراض. <strong>توقف عن تناول أوجمنتين.</strong></p><p dir="RTL"><strong>التفاعلات الجلدية الخطيرة&nbsp; </strong></p><p dir="RTL">هذه نادرة لدى الأشخاص الذين يتناولون أوجمنتين، وتشمل:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي الذي قد يتحول إلى قرح، ويبدو كبقع صغيرة )بقع مركزية داكنة محاطة بمنطقة شاحبة مع حلقات داكنة حول الحافة</p><p dir="RTL">- حمامي متعددة الأشكال(</p><p dir="RTL">هذه نادرة جدًاً لدى الأشخاص الذين يتناولون أوجمنتين، وتشمل:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي منتشر مع ظهور بثور وتقشر الجلد، خاصة حول الفم والأنف والعينين والأعضاء التناسلية) متلازمة ستيفنز- جونسون(، والشكل الأكثر حدة يسبب بثورًا وتقشرًا للجلد على معظم سطح الجسم)انحلال البشرة السمي(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر منتشر مع ظهور بثور صغيرة بها صديد)البثور ذو الطفح الجلدي الظاهر(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أحمر متقشر مثير للحكة مع ظهور رضوض تحت الجلد وبثور) التهاب الجلد التقشري الفقاعي(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض شبيهة بالإنفلونزا مع الطفح الجلدي، والحمى، وتضخم الغدد، ونتائج غير طبيعية لتحاليل الدم )بما في ذلك خلايا الدم البيضاء) فرط الحمضات( وإنزيمات الكبد( )تفاعل الدواء مع فرط الحمضات والأعراض الجهازية(.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يظهر عادة طفح جلدي أحمر على الأرداف كلتيهما، والجزء العلوي الداخلى من الفخذين، وتحت الإبطين، والرقبة( الطفح الجلدي وبين الثنايا المتماثل والمتعلق بالدواء(SDRIFE)).</p><p dir="RTL">&ccedil;<strong>احصل على المساعدة الطبية فورًا</strong> إذا ظهرت عليك أي من هذه الأعراض. <strong>توقف عن تناول أوجمنتين. </strong></p><p dir="RTL"><strong>مشاكل خطيرة بالكبد&nbsp; </strong></p><p dir="RTL">في حالات نادرة، يمكن أن تسبب&nbsp; الأدوية مثل &lt; اوجمنتين&gt; مشاكل بالكبد، مما يؤدي إلى اصفرار الجلد و/ أو بياض العين.&nbsp;</p><p dir="RTL">&ccedil;اتصل بطبيبك في أقرب وقت ممكن إذا ظهرت عليك أي من هذه الأعراض.&nbsp;</p><p dir="RTL"><strong>الإسهال الشديد</strong><strong>) </strong><strong>التهاب القولون الغشائي الكاذب</strong><strong>(</strong><strong>&nbsp; </strong></p><p dir="RTL">في حالات نادرة، يمكن أن تسبب&nbsp; الأدوية مثل &lt; اوجمنتين&gt; التهاب القولون )الأمعاء الغليظة( الذي يسبب الإسهال ويكون عادة مصحوب بالدم والمخاط وآلام في المعدة والحمى.</p><p dir="RTL">&ccedil;اتصل بطبيبك في أقرب وقت ممكن إذا ظهرت عليك أي من هذه الأعراض.&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الشائعة جدًا&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى<strong> أكثر من </strong>شخص واحد من بين كل <strong>10</strong> أشخاص:&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال )عند البالغين.(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الآثار الجانبية الشائعة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>10</strong> أشخاص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلاع )عدوى فطرية تسببها المبيضة وتصيب المهبل أو الفم أو ثنايا الجلد(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالغثيان) الدوار(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال)عند الأطفال(&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية غير الشائعة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>100</strong> شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوخة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي البارز المثير للحكة) &nbsp;الشرى (</p><p dir="RTL">الآثار الجانبية غير الشائعة التي قد تظهر في تحاليل الدم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في بعض المواد )الإنزيمات( التي ينتجها الكبد&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية النادرة&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>1000</strong> شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي الذي قد يتحول إلى قرح، ويبدو كبقع صغيرة)بقع مركزية داكنة محاطة بمنطقة شاحبة مع حلقات داكنة حول الحافة - حمامي متعددة الأشكال)(انظر&quot; التفاعلات الجلدية الخطيرة&quot; سابقًا في القسم &nbsp;4)</p><p dir="RTL">الآثار الجانبية النادرة التي قد تظهر في تحاليل الدم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء) قلة الكريات البيضاء، بما في ذلك قلة العدلات(&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الخلايا التي تساعد على تجلط الدم) قلة الصفيحات(</p><p dir="RTL"><strong>الآثار الجانبية النادرة جدًا&nbsp; </strong></p><p dir="RTL">قد تظهر هذه الأعراض لدى شخص<strong> واحد</strong> من بين كل <strong>10,000 </strong>شخص:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل التحسسية الشديدة) انظر أيضا &quot;<strong>ردود الفعل التحسسية الشديدة</strong>&quot; سابقا في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفاعلات الجلدية الخطيرة) انظر أيضا <strong>&quot;التفاعلات الجلدية الخطيرة</strong>&quot; سابقا في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد) التهاب الكبد الوبائي( )انظر أيضا &quot;<strong>المشاكل الخطيرة بالكبد</strong>&quot; سابقا في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار بياض العين أو الجلد) &nbsp;اليرقان( )انظر أيضا &quot;<strong>المشاكل الخطيرة بالكبد</strong>&quot; سابقا في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء الغليظة)انظر أيضا &quot;<strong>الإسهال الحاد</strong>&quot; سابقا في القسم 4)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكلية) الالتهاب الكلوي(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الوقت الذي يستغرقه الدم للتجلط</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النشاط غير المعتاد)فرط النشاط(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات) التشنجات(&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اللسان الأسود الذي يبدو مشعرًا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الغشاء الواقي المحيط بالدماغ )التهاب السحايا العقيم(&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;طفح جلدي مع ظهور بثور مرتبة بشكل دائري مع تقشر مركزي أو مثل سلسلة من اللآلئ (داء الجلوبولين المناعيأ الخطي).</p><p dir="RTL">الآثار الجانبية النادرة جدًاً التي قد تظهر في تحاليل الدم أو البول :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض حاد في عدد خلايا الدم البيضاء) ندرة المحببات(&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تدمير خلايا الدم الحمراء بسرعة كبيرة) فقر الدم الانحلالي(</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بلورات في البول</p><p>&ccedil; <strong>تحدث إلى&nbsp; طبيبك أو الصيدلي</strong> إذا أصبحت أي من الآثار الجانبية المذكورة <strong>شديدة أو مزعجة</strong>، أو إذا لاحظت أي آثار جانبية غير&nbsp; مدرجة في هذه النشرة الطبية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يحفظ هذا الدواء بعيدًا عن رؤية ومتناول الأطفال.&nbsp; </strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول أوجمنتين بعد تاريخ انتهاء الصلاحية المدون على العبوة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحُفظ هذا الدواء في العلبة الأصلية في مكان جاف لحمايته من الرطوبة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحتوي على كيس مجفف، لا تزيله أو تتناوله. &nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تخزن كيس شريط تغليف الأدوية المفتوح في درجة حرارة أعلى من 25<sup> </sup>م&deg;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تخلص من الأقراص المفتوحة وغير المستخدمة بعد مرور 30 يوم من تفحهها&nbsp;&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية عن طريق إلقائها في مياه الصرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا يحتوي أوجمنتين&nbsp;&nbsp; محتويات أوجمنتين&nbsp; </strong></p><p dir="RTL">الأموكسيسيلين وحمض الكلافولانيك هما المواد الفعالة في هذا الدواء.</p><p dir="RTL">تأتي أقراص أوجمنتين بتركيزات&nbsp; مختلفة.</p><p dir="RTL">يحتوي كل قرص على أي مما يلي:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull; أموكسيسيلين ثلاثي الهيدرات بما يعادل&nbsp; 250&nbsp; مجم من الأموكسيسيلين، وبوتاسيوم كلافولانات بما يعادل&nbsp; 125&nbsp; مجم من حمض الكلافولانيك&nbsp;</p><p dir="RTL">&bull; أموكسيسيلين ثلاثي الهيدرات بما يعادل&nbsp; 500 مجم من الأموكسيسيلين&nbsp; ،وبوتاسيوم كلافولانات بما يعادل&nbsp; 125 مجم من حمض الكلافولانيك&nbsp;</p><p dir="RTL">المكونات الأخرى هي:&nbsp;</p><p dir="RTL">يحتوي كل قرص على سترات الماغنيسيوم، جلايكولات نشا الصوديوم، السيليكا الغروية، سليولوز دقيق التبلور، ثاني أكسيد التيتانيوم (171E)، هيدروكسي پروپيل ميثيل سليولوز، پولي إيثيلين جلايكول وزيت السيلكون .</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو</strong> <strong>أوجمنتين&nbsp; وما هي محتويات العبوة </strong></p><p dir="RTL">أقراص أوجمنتين 375 ملجم: أقراص بيضاء إلى شبه بيضاء بيضاوية الشكل مكسوة بكسوة غشائية منقوش على أحد وجهيها Augmentin. عبوات فقاعية سعة 20 قرص في العبوة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أقراص أوجمنتين 625 ملجم: أقراص بيضاء إلى شبه بيضاء بيضاوية الشكل مكسوة بكسوة غشائية منقوش على أحد وجهيها&quot; AC&quot; مع خط منصف والوجه الآخر أملس. عبوات فقاعية سعة 20 قرص في العبوة .</p><p dir="RTL">&nbsp;</p><p dir="RTL">لاتتوافر جميع أشكال العبوات في كل بلد</p><p dir="RTL">العلامات التجارية مملوكة أو مرخصة لمجموعة شركات جلاكسو سميث كلاين&nbsp;</p><p dir="RTL">حقوق النشر لعام 2024&copy; محفوظة لمجموعة شركات جلاكسو سميث كلاين جميع الحقوق محفوظة<strong>. </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>تصنيع:&nbsp; </strong></p><p dir="RTL">سميث كلاين بيتشام پي إل سي.* ورثينج، المملكة المتحدة .</p><p dir="RTL"><strong>تعبئة وتسويق:&nbsp; </strong></p><p dir="RTL">جلاكسو العربية السعودية المحدودة* جدة ،المملكة العربية السعودية.</p><p dir="RTL">*عضو في مجموعة شركات جلاكسو سميث كلاين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للاستفسار عن أية معلومات عن هذا المستحضر الدوائي، يرجى الاتصال بالأرقام التالية:&nbsp; </strong></p><p dir="RTL">جلاكسو سميث كلاين، المكتب الرئيسي، جدة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هاتف 6536666 )12( 966 +</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جوّال:&nbsp; 9882-904-56966 +</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: gcc.medinfo@gsk.com</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب 55850، جدة 21544، المملكة العربية السعودية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:roundrect
 id="Rectangle_x003a__x0020_Rounded_x0020_Corners_x0020_1" o:spid="_x0000_s1026"
 style='position:absolute;left:0;text-align:left;margin-left:21.5pt;
 margin-top:1.95pt;width:467pt;height:261pt;z-index:251664384;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:middle'
 arcsize="10923f" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokecolor="black [3213]" strokeweight="2.25pt">
 <v:stroke joinstyle="miter"/>
</v:roundrect><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن أي آثار جانبية:</strong></p><p dir="RTL"><strong><em>المملكة العربية السعودية</em></strong></p><p dir="RTL"><strong>- المركز الوطني للتيقظ والسلامة الدوائية (</strong><strong>NPC</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الاتصال بالرقم الموحد: 19999</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa</p><p dir="RTL"><strong>- </strong><strong>جلاكسو سميث كلاين &ndash; المكتب الرئيسي، جدة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; هاتف: 6536666 )12( 966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; جوال:9882-904-56966 +</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: saudi.safety@gsk.com</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://gskpro.com/en-sa/<u> </u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ص.ب. 55850، جدة 21544، المملكة العربية السعودية</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            رقم الإصدار:29 GDS
تاريخ الإصدار:  7 سبتمبر 2023

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN TID Tablet.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN 375 mg tablets: Each tablet contains 250 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate).
AUGMENTIN 625 mg tablets: Each tablet contains 500 mg amoxicillin (as amoxicillin trihydrate) and 125 mg clavulanic acid (as potassium clavulanate).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN 375 mg tablets: A white to off-white oval-shaped film-coated tablet, debossed with ‘Augmentin’ on one side
AUGMENTIN 625 mg tablets: A white to off-white oval-shaped film-coated tablet debossed with ‘AC’ and a score line on one side and plain on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>AUGMENTIN</em> is an antibiotic agent with a notably broad-spectrum of activity against the commonly occurring bacterial pathogens in general practice and hospital.&nbsp; The beta lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace a wider range of organisms, including many resistant to other beta -lactam antibiotics.</p><p><em>AUGMENTIN</em> should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data.</p><p><em>AUGMENTIN</em> oral presentations for three times daily dosing, are indicated for short-term treatment of bacterial infections at the following sites:</p><p><em>Upper respiratory tract infections (including ENT) </em>e.g. recurrent tonsillitis, sinusitis, otitis media.</p><p><em>Lower respiratory tract infections </em>e.g. acute exacerbation of chronic obstructive pulmonary disease (AECOPD)/acute exacerbation of chronic bronchitis (AECB), lobar and bronchopneumonia.</p><p><em>Genito-urinary tract infections </em>e.g. cystitis, urethritis, pyelonephritis.</p><p><em>Skin and soft tissue infections,</em> e.g. boils, abscesses, cellulitis, wound infections.<em> </em></p><p><em>Bone and joint infections </em>e.g. osteomyelitis.</p><p><em>Dental infections</em> e.g. dentoalveolar abscess</p><p><em>Other infections </em>e.g. intra-abdominal sepsis.</p><p>Susceptibility to <em>AUGMENTIN</em> will vary with geography and time (see <em>Pharmacological Properties, Pharmacodynamics </em>for further information). Local susceptibility data should be consulted where available, and microbiological sampling and susceptibility testing performed where necessary.</p><p>Infections caused by amoxicillin -susceptible organisms are amenable to <em>AUGMENTIN<strong> </strong></em>treatment due to its amoxicillin content. Mixed infections caused by amoxicillin susceptible organisms in conjunction with <em>AUGMENTIN</em> -susceptible beta -lactamase producing organisms may therefore be treated with <em>AUGMENTIN</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmaceutical form: Film-coated tablet&nbsp;</p><p>Dosage depends on the age, weight and renal function of the patient and the severity of the infection.</p><p>Dosages are expressed throughout in terms of amoxicillin/clavulanate content except when doses are stated in terms of an individual component.</p><p>To minimise potential gastrointestinal intolerance, administer at the start of a meal. The absorption of AUGMENTIN is optimised when taken at the start of a meal.</p><p>Treatment should not be extended beyond 14 days without review.</p><p>Therapy can be started parenterally and continued with an oral preparation.</p><p>&nbsp;</p><p><strong><em>Adults and Children over 12 years </em></strong></p><p>AUGMENTIN tablets are not recommended in children of 12 years and under.</p><p>The usual recommended daily dosage is:<em> </em></p><table border="0" cellspacing="0" cellpadding="0" style="width:543px"><tbody><tr><td style="vertical-align:top"><p>Mild - Moderate infections</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>One AUGMENTIN 375 mg tablet every</p><p>8 hours.</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Severe infections</p></td><td style="vertical-align:top"><p>Two AUGMENTIN 375 mg tablets every 8 hours.&nbsp;</p><p>OR</p><p>One AUGMENTIN 625mg tablet every 8 hours.</p><p>&nbsp;</p></td></tr></tbody></table><p><strong><em>Renal Impairment </em></strong></p><p><strong><em>Adults </em></strong></p><p>Dosage adjustments are based on the maximum recommended level of amoxicillin.</p><p>No adjustment in dose is required in patients with creatinine clearance (CrCl) greater than 30 mL/min.</p><table border="0" cellspacing="0" cellpadding="0" style="width:577px"><tbody><tr><td style="vertical-align:top"><p>CrCl 10-30 mL/min&nbsp;</p></td><td style="vertical-align:top"><p>The usual recommended dose of AUGMENTIN 375 mg OR AUGMENTIN 625 mg tablets given every 12 hours.</p></td></tr><tr><td style="vertical-align:top"><p>CrCl &lt; 10 mL/min</p></td><td style="vertical-align:top"><p>The usual recommended dose of AUGMENTIN 375 mg OR AUGMENTIN 625 mg tablets given every 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p>Haemodialysis</p></td><td style="vertical-align:top"><p>The usual recommended dose of AUGMENTIN 375mg OR AUGMENTIN 625 mg tablets given every 24</p><p>hours, plus a further dose during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased).</p></td></tr></tbody></table><p><strong><em>&nbsp;</em></strong></p><p><strong><em>Hepatic Impairment</em></strong><em> </em></p><p>Administer with caution; monitor hepatic function at regular intervals.</p><p>Each <em>AUGMENTIN</em> 375 mg tablet contains 0.63 mmol (25 mg) of potassium</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AUGMENTIN is contra-indicated in patients with a history of hypersensitivity to betalactams, e.g. penicillins and cephalosporins. 
 
AUGMENTIN is contra-indicated in patients with a previous history of AUGMENTINassociated jaundice/hepatic dysfunction. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Before initiating therapy with <em>AUGMENTIN</em>, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other allergens.</p><p>Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy.&nbsp; These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity (see Contraindications). Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction.</p><p>Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to AUGMENTIN ES (see Undesirable effects). Drug-induced enterocolitis syndrome (DIES) has been reported mainly in children receiving AUGMENTIN ES (see Undesirable effects). DIES is an allergic reaction with the leading symptom of protracted vomiting (1-4 hours after medicinal product administration) in the absence of allergic skin or respiratory symptoms. Further symptoms could comprise abdominal pain,<strong> </strong>diarrhoea, hypotension or leucocytosis with neutrophilia. In severe cases, drug-induced enterocolitis syndrome can progress to shock. If an allergic reaction occurs, AUGMENTIN ES therapy should be discontinued and appropriate alternative therapy instituted.</p><p>&nbsp;Serious anaphylactic reactions require immediate emergency treatment with adrenaline. Oxygen, intravenous (i.v.) steroids and airway management, including intubation may also be required.</p><p><em>AUGMENTIN</em> should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.</p><p>Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.</p><p>Pseudomembranous colitis has been reported with the use of antibiotics and may range in severity from mild to life-threatening. Therefore, it is important to consider its diagnosis in patients who develop diarrhoea during or after antibiotic use. If prolonged or significant diarrhoea occurs or the patient experiences abdominal cramps, treatment should be discontinued immediately and the patient investigated further.</p><p>Abnormal prolongation of prothrombin time (increased INR) has been reported rarely in patients receiving <em>AUGMENTIN</em> and oral anticoagulants.&nbsp; Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently.&nbsp; Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.</p><p>Changes in liver function tests have been observed in some patients receiving <em>AUGMENTIN</em>. The clinical significance of these changes is uncertain but <em>AUGMENTIN</em> should be used with caution in patients with evidence of hepatic dysfunction.</p><p>Cholestatic jaundice, which may be severe, but is usually reversible, has been reported rarely. Signs and symptoms may not become apparent for up to six weeks after treatment has ceased.</p><p>In patients with renal impairment <em>AUGMENTIN</em> dosage should be adjusted as recommended in the <em>Dosage and Administration</em> section.</p><p>In patients with reduced urine output, crystalluria (including acute renal injury) has been observed very rarely, predominantly with parenteral therapy. During the administration of high doses of amoxicillin, it is advisable to maintain adequate fluid intake and urinary output in order to reduce the possibility of amoxicillin crystalluria. In patients with bladder catheters, a regular check of patency should be maintained (see Undesirable effects and Overdose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Concomitant use of probenecid is not recommended. Probenecid decreases the renal tubular secretion of amoxicillin. Concomitant use with <em>AUGMENTIN</em> may result in increased and prolonged blood levels of amoxicillin but not of clavulanic acid.</p><p>Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of <em>AUGMENTIN</em><strong> </strong>and allopurinol.</p><p>In common with other antibiotics, <em>AUGMENTIN</em> may affect the gut flora, leading to lower oestrogen reabsorption and reduced efficacy of combined oral contraceptives.</p><p>In the literature, there are rare cases of increased international normalised ratio in patients maintained on acenocoumarol or warfarin and prescribed a course of amoxicillin.&nbsp; If coadministration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of <em>AUGMENTIN</em>.</p><p>&nbsp;</p><p>In patients receiving mycophenolate mofetil, reduction in pre-dose concentration of the active metabolite mycophenolic acid of approximately 50% has been reported following commencement of oral amoxicillin plus clavulanic acid. The change in pre-dose level may not accurately represent changes in overall MPA exposure.</p><p>Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category B: Reproduction studies in animals (mice and rats at doses up to 10 times the human dose) with orally and parenterally administered <em>AUGMENTIN</em> have shown no teratogenic effects.&nbsp; In a single study in women with pre-term, premature rupture of the foetal membrane (pPROM), it was reported that prophylactic treatment with <em>AUGMENTIN</em> may be associated with an increased risk of necrotising enterocolitis in neonates. As with all medicines, use should be avoided in pregnancy, especially during the first trimester, unless considered essential by the physician.</p><p>&nbsp;</p><p><em>AUGMENTIN</em> may be administered during the period of lactation.&nbsp; With the exception of the risk of sensitisation, associated with the excretion of trace quantities in breast milk, there are no known detrimental effects for the breast-fed infant.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse effects on the ability to drive or operate machinery have not been observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Data from large clinical trials was used to determine the frequency of very common to rare undesirable effects. The frequencies assigned to all other undesirable effects (i.e. those occurring at &lt;1/10,000) were mainly determined using post-marketing data and refer to a reporting rate rather than a true frequency.&nbsp;</p><p>The following convention has been used for the classification of frequency:</p><p>very common &ge;1/10</p><p>common &ge;1/100 to &lt;1/10&nbsp;</p><p>uncommon &ge;1/1000 to&lt;1/100&nbsp;</p><p>rare &ge;1/10,000 to &lt;1/1000&nbsp;</p><p>very rare &lt;1/10,000.&nbsp;&nbsp;</p><p><strong>Infections and infestations &nbsp;&nbsp; &nbsp;&nbsp;</strong></p><p>Common&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mucocutaneous candidiasis</p><p><strong>Blood and lymphatic system disorders&nbsp; </strong></p><p>Rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible leucopenia (including neutropenia) and thrombocytopenia.</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible agranulocytosis and haemolytic anaemia. Prolongation of bleeding time and prothrombin time</p><p><strong>Immune system disorders&nbsp; </strong></p><p>Very Rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Angioneurotic oedema, anaphylaxis (see<em> Special warnings &amp; precautions for use</em>) , serum sickness-like syndrome, hypersensitivity vasculitis (see also <em>Skin and subcutaneous tissue disorders</em>).</p><p><strong>Nervous system disorders </strong></p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp; Dizziness, headache&nbsp;</p><p>Very rare&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible hyperactivity, aseptic meningitis, convulsions. Convulsions may occur in patients with impaired renal function or in those receiving high doses.</p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aseptic meningitis</p><p>Cardiac disorders <!--[if supportFields]><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>DOCVARIABLE
vault_nd_db1a0819-de14-4ecb-8873-af40b348260c \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kounis syndrome (see<em> Special warnings and precautions for use</em>).<strong> Gastrointestinal disorders</strong></p><p><strong><em>Adults</em></strong>:</p><p>Very common&nbsp; Diarrhoea</p><p>Common&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Nausea, vomiting</p><p><strong><em>Children: </em></strong></p><p>Common&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea, nausea, vomiting</p><p><strong><em>All populations </em></strong></p><p>Nausea is more often associated with higher oral dosages. If gastrointestinal reactions are evident, they may be reduced by taking <em>AUGMENTIN</em> at the start of a meal.</p><p>Uncommon &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indigestion&nbsp;</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antibiotic-associated colitis (including pseudomembranous colitis and haemorrhagic colitis)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Black hairy tongue</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Superficial tooth<strong> </strong>discolouration has been reported very rarely in children. Good oral hygiene may help to prevent tooth discolouration as it can usually be removed by brushing<strong>. </strong></p><p>Not known &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Drug-induced enterocolitis syndrome (see Special warnings and precautions for use), Pancreatitis acute.</p><p><strong>Hepatobiliary disorders&nbsp; </strong></p><p>Uncommon&nbsp; &nbsp;&nbsp; A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hepatitis and cholestatic jaundice. These events have been noted with other penicillins and cephalosporins.&nbsp;</p><p>Hepatic events have been reported predominantly in males and elderly patients and may be associated with prolonged treatment. These events have been very rarely reported in children.</p><p>&nbsp;</p><p>Signs and symptoms usually occur during or shortly after treatment but in some cases may not become apparent until several weeks after treatment has ceased.&nbsp; These are usually reversible. Hepatic events may be severe and in extremely rare circumstances, deaths have been reported<strong>.</strong> These have almost always occurred in patients with serious underlying disease or taking concomitant medications known to have the potential for hepatic effects.</p><p><strong>Skin and subcutaneous tissue disorders&nbsp; </strong></p><p>Uncommon&nbsp; &nbsp;&nbsp;&nbsp; Skin rash, pruritus, urticaria&nbsp;</p><p>Rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erythema multiforme</p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; exfoliative-dermatitis, acute generalised exanthemous pustulosis (AGEP) ,</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drug reaction with eosinophilia and systemic symptoms (DRESS),</p><p>and symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) (baboon syndrome) (see also <em>Immune system disorders</em>).</p><p>If any hypersensitivity dermatitis reaction occurs, treatment should be discontinued.</p><p>Linear IgA disease.</p><p><strong>Renal and urinary disorders&nbsp; </strong></p><p>Very rare &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interstitial nephritis</p><p>Not known&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Crystalluria (including acute renal injury) (see Overdose).</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>Kingdom of Saudi Arabia</em></strong></p><p><strong>-National Pharmacovigilance centre (NPC)</strong></p><ul><li><ul><li>Reporting Hotline: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul></li></ul><p><strong>-GSK - Head Office, Jeddah</strong></p><ul><li><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: saudi.safety@gsk.com<u> &nbsp;</u></li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul></li></ul><p><strong>&nbsp;</strong></p><p><strong>For any information about this medicinal product, please contact:</strong></p><p><strong>GSK - Head Office, Jeddah</strong></p><ul><li><ul><li>Tel:&nbsp; +966-12-6536666</li><li>Mobile: +966-56-904-9882</li><li>Email: gcc.medinfo@gsk.com</li><li>Website: https://gskpro.com/en-sa/</li><li>P.O. Box 55850, Jeddah 21544, Saudi Arabia</li></ul></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Gastrointestinal symptoms may be treated symptomatically with attention to the water electrolyte balance.&nbsp;</p><p>Amoxicillin crystalluria, in some cases leading to renal failure, has been observed<em> (</em>see <em>Warnings and Precautions). </em></p><p>&nbsp;</p><p><em>AUGMENTIN</em> can be removed from the circulation by haemodialysis.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: J01CR02.</p><p>Pharmacotherapeutic group: Combinations of penicillins, incl. beta-lactamase inhibitors.</p><p>Resistance to many antibiotics is caused by bacterial enzymes which destroy the antibiotic before it can act on the pathogen. The clavulanate in <em>AUGMENTIN</em> anticipates this defence mechanism by blocking the beta-lactamase enzymes, thus rendering the organisms susceptible to amoxicillin&rsquo;s rapid bactericidal effect at concentrations readily attainable in the body.</p><p>&nbsp;Clavulanate by itself has little antibacterial activity; however, in association with amoxicillin as <em>AUGMENTIN</em> it produces an antibiotic agent of broad-spectrum with wide application in hospital and general practice.</p><p>In the list below, organisms are categorised according to their <em>in vitro </em>susceptibility to</p><p><em>AUGMENTIN</em>.</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:575px"><tbody><tr><td style="vertical-align:top"><p><strong><em>In vitro</em> susceptibility of micro-organisms to <em>AUGMENTIN</em></strong></p><p>&nbsp;</p><p>Where clinical efficacy of <em>AUGMENTIN</em> has been demonstrated in clinical trials this is indicated with an asterisk (*).</p><p>&nbsp;</p><p>Organisms that do not produce beta-lactamase are identified (with <sup>&dagger;</sup>).&nbsp; If an isolate is susceptible to amoxicillin, it can be considered susceptible to <em>AUGMENTIN. </em></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>C<strong>ommonly susceptible species</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Bacillius anthracis </em></p><p><em>Enterococcus faecalis </em></p><p><em>Listeria monocytogenes </em></p><p><em>Nocardia asteroides </em></p><p><em>Streptococcus pyogenes*</em><sup>&dagger;</sup><em> </em></p><p><em>Streptococcus agalactiae*</em><sup>&dagger;</sup><em> </em></p><p><em>Streptococcus</em> spp. (other beta-hemolytic)<em> *</em><sup>&dagger;</sup></p><p><em>Staphylococcus aureus</em> (methicillin susceptible)*</p><p><em>Staphylococcus saprophyticus</em> (methicillin susceptible)</p><p>Coagulase negative staphylococcus (methicillin susceptible)&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:575px"><tbody><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Bordetella pertussis </em></p><p><em>Haemophilus influenzae* </em></p><p><em>Haemophilus parainfluenzae</em></p><p><em>Helicobacter pylori </em></p><p><em>Moraxella catarrhalis* </em></p><p><em>Neisseria gonorrhoeae<sup> </sup></em></p><p><em>Pasteurella multocida </em></p><p><em>Vibrio cholerae</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other:</u></p><p><em>Borrelia burgdorferi<sup> </sup></em></p><p><em>Leptospira ictterohaemorrhagiae </em></p><p><em>Treponema pallidum</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram positive anaerobes:</u></p><p><em>Clostridium </em>spp.</p><p><em>Peptococcus niger </em></p><p><em>Peptostreptococcus magnus </em></p><p><em>Peptostreptococcus micros </em></p><p><em>Peptostreptococcus</em> spp.</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative anaerobes:</u></p><p><em>Bacteroides fragilis Bacteroides</em> spp.</p><p><em>Capnocytophaga</em> spp.</p><p><em>Eikenella corrodens </em></p><p><em>Fusobacterium nucleatum </em></p><p><em>Fusobacterium</em> spp.</p><p><em>Porphyromonas</em> spp.</p><p><em>Prevotella</em> spp.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Species for which acquired resistance may be a problem</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Escherichia coli* </em></p><p><em>Klebsiella oxytoca Klebsiella pneumoniae* Klebsiella</em> spp.</p><p><em>Proteus mirabilis </em></p><p><em>Proteus vulgaris Proteus</em> spp.</p><p><em>Salmonella</em> spp.</p><p>Shigella spp.&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-positive aerobes:</u></p><p><em>Corynebacterium</em> spp.<sup> </sup></p><p><em>Enterococcus faecium&nbsp; </em></p><p><em>Streptococcus pneumoniae*</em><sup>&dagger;<em> </em></sup></p><p>Viridans group streptococcus</p></td></tr><tr><td style="vertical-align:top"><p><strong>Inherently resistant organisms</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Gram-negative aerobes:</u></p><p><em>Acinetobacter</em> spp. <em>Citrobacter freundii Enterobacter</em> spp.</p><p><em>Hafnia alvei </em></p><p><em>Legionella pneumophila </em></p><p><em>Morganella morganii Providencia </em>spp.</p><p><em>Pseudomonas</em> spp.</p><p><em>Serratia</em> spp.</p><p><em>Stenotrophomas maltophilia </em></p><p><em>Yersinia enterolitica</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Others:</u></p><p><em>Chlamydia pneumoniae </em></p><p><em>Chlamydia psittaci </em></p><p><em>Chlamydia spp.&nbsp; </em></p><p><em>Coxiella burnetti </em></p><p><em>Mycoplasma spp. </em></p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of the two components of <em>AUGMENTIN</em> are closely matched. Peak serum levels of both occur about 1 hour after oral administration. Absorption of <em>AUGMENTIN</em> is optimised at the start of a meal.</p><p>Doubling the dosage of <em>AUGMENTIN</em> approximately doubles the serum levels achieved.</p><p>Both clavulanate and amoxicillin have low levels of serum binding; about 70% remains free in the serum.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No further information of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each tablet contains magnesium stearate, sodium starch glycollate, colloidal silica, microcrystalline cellulose, titanium dioxide (E171), hydroxypropyl methylcellulose, polyethylene glycol and dimeticone (silicone oil).</p><p>For important information about some of these excipients see Special warnings and precautions for use.</p><p><em>AUGMENTIN</em> presentations do not contain sucrose, tartrazine or any other azo dyes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The expiry date is indicated on the packaging.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The storage conditions are detailed on the packaging Do not take after the expiry date shown on the pack.</p><p>Store in a dry place in the original packaging to protect from moisture.</p><p>Refer to pack for storage temperature.</p><p>For AUGMENTIN tablet packs with a storage temperature up to 25&deg;C. Use tablets within 30 days of opening (see also Instructions for Use/Handling).</p><p>AUGMENTIN tablet packs contain desiccant sachets. Do not remove or eat.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablets are supplied in a carton containing blister packs. Each blister pack is stored within a sealed pouch, with a desiccant sachet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blister pouches contains a desiccant sachet; do not remove or eat.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>Discard any opened and unused tablets after storing as directed on the packaging.</p><p>Not all presentations are available in every country<em>. </em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 
Trademarks are owned by or licensed to the GSK group of companies  
© 2024 GSK, all rights reserved. 
 
Manufactured by:  
SmithKline Beecham plc.* Worthing, UK 
Packed & MAH: Glaxo Saudi Arabia Ltd.*, Jeddah, KSA 
*member of GlaxoSmithKline group of companies 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 
Version number: GDS29/IPI19 
Date of issue:  07 September 2023




            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>